[PDF][PDF] Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience
F Kharouf, A Kenig, E Bohbot, L Rubin… - Clin Exp …, 2023 - clinexprheumatol.org
Objective Higher-level evidence is required to discern whether the incidence of idiopathic
inflammatory myopathies (IIM) has increased during the COVID-19 pandemic and whether …
inflammatory myopathies (IIM) has increased during the COVID-19 pandemic and whether …
New-onset immune-mediated necrotizing myopathy and trigeminal neuropathy after SARS-CoV-2 mRNA vaccination in a patient with rheumatoid arthritis and …
TT Wada, K Yokota, F Inayoshi, S Sakai… - Internal …, 2023 - jstage.jst.go.jp
We present the case of a 42-year-old woman with rheumatoid arthritis and Sjögren's
syndrome treated with adalimumab who developed immune-mediated necrotizing myopathy …
syndrome treated with adalimumab who developed immune-mediated necrotizing myopathy …
Elderly-onset inflammatory myopathy associated with Sjögren's syndrome following SARS-CoV-2 vaccination
Y Komori, S Kobayashi, K Hatano… - Modern …, 2025 - academic.oup.com
As vaccination against SARS-CoV-2 has progressed, various autoimmune diseases,
including inflammatory myopathies, have been reported to develop after vaccination …
including inflammatory myopathies, have been reported to develop after vaccination …